S. Manzi et al., AGE-SPECIFIC INCIDENCE RATES OF MYOCARDIAL-INFARCTION AND ANGINA IN WOMEN WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON WITH THE FRAMINGHAM-STUDY, American journal of epidemiology, 145(5), 1997, pp. 408-415
The authors ascertained cardiovascular events (myocardial infarction a
nd angina pectoris) in 498 women with systemic lupus erythematosus see
n at the University of Pittsburgh Medical Center from 1980 to 1993 (3,
522 person-years), Subjects were stratified by age, and cardiovascular
event incidence rates were determined. The authors compared these rat
es with cardiovascular event rates occurring over the same time period
in 2,208 women of similar age participating in the Framingham Offspri
ng Study (17,519 person-years), Age-specific rate ratios were computed
to determine whether the cardiovascular events in the lupus cohort we
re greater than expected, The risk factors associated with cardiovascu
lar events in women with lupus were determined. There were 33 first ev
ents (11 myocardial infarction, 10 angina pectoris, and 12 both angina
pectoris and myocardial infarction) after the diagnosis of lupus; two
thirds were under the age of 55 years at the time of event, Women wit
h lupus in the 35- to 44-year age group were over 50 times more likely
to have a myocardial infarction than were women of similar age in the
Framingham Offspring Study (rate ratio = 52.43, 95% confidence interv
al 21.6-98.5), Older age at lupus diagnosis, longer lupus disease dura
tion, longer duration of corticosteroid use, hypercholesterolemia, and
postmenopausal status were more common in the women with lupus who ha
d a cardiovascular event than in those who did not have an event, Prem
ature cardiovascular disease is much more common in young premenopausa
l women with lupus than in a population sample, With the increased lif
e expectancy of lupus patients due to improved therapy, cardiovascular
disease has emerged as a significant threat to the health of these wo
men, The impact of this problem has been underrecognized, with little
focus placed on aggressive management of hypercholesterolemia and othe
r possible risk factors.